AIDS and Periodontium
AIDS and Periodontium
AIDS and Periodontium
AIDS
Modes of Transmission
Category B
Bacillary angiomatosis
Candidiasis, oropharyngeal (thrush)
Candidiasis, vulvovaginal; persistent, frequent, or
poorly responsive to therapy
Cervical dysplasia (moderate or severe)/cervical
carcinoma in situ
Constitutional symptoms, such as fever (38.5 C)
or diarrhea lasting greater than 1 month
Category C
Clinical conditions listed in the AIDS surveillance
case definition.
Symptoms
Few weeks to months.
Acute symptoms-malaise, fatigue, fever, myalgia,
erythematous cutaneous eruption, oral
candidiasis, oral ulcerations, and
thrombocytopenia.
Duration - 2 weeks.
Seroconversion occurs 3 to 8 weeks later.
Oral Manifestations
Commonly occuring oral candidiasis
oral hairy leukoplakia
atypical periodontal diseases
oral Kaposi's sarcoma, and
oral non-Hodgkin's lymphoma
Less common - melanotic hyperpigmentation,
mycobacterial
infections, necrotizing ulcerative stomatitis, miscellaneous
oral ulcerations, and viral infections.
Oral Candidiasis
Most common - 90% of AIDS patients.
Diminished host resistance
debilitated patients , patients
receiving immunosuppressive therapy.
Oppurtunistic prolonged antibiotic
therapy.
Most oral candidal infections (85% to
95%) are associated with Candida
albicans.
Non-C. albicans infections are more
common among immunocompromised
individuals already receiving
antifungal therapy for C. albicans.
Diagnosis
microscopic examination of a tissue sample or smear.
hyphae and yeast forms.
Treatment
topical and systemic antifungal agents.
Amphotericin B oral suspension is more effective
against
Candida albicans.
Ketaconazole-systemic therapy.
refractory or recurrent.
30% of AIDS related candidiasis relapse within 4 weeks
of treatment and 60% to 80% within 3 months .
Treatment
Laser or conventional surgery.
systemic antiviral agents such as acyclovir.
Kaposis Sarcoma
Multifocal, vascular neoplasm.
Probable causative organismhuman herpes virus-8 (HHV-8).
HIV-infected individuals are
7000-fold more likely to
develop KS.
localized and slowly growing
lesion. In HIV individuals aggressive lesion.
Majority (71%) develop lesions
of the oral mucosa, particularly
the palate and gingiva.
Differential Diagnosis
Pyogenic granuloma, hemangioma, atypical
hyperpigmentation, sarcoidosis, bacillary angiomatosis,
angiosarcoma, pigmented nevi, and cat-scratch disease.
Management
Antiretroviral agents, laser excision, radiation therapy, or
intralesional injection with vinblastine or interferon a.
Tendency to recur.
Destructive periodontitis scaling and root planing.
Histopathology
Increased blood vessels.
Lack of infammatory cell infiltrate.
Treatment
Non-responsive to therapy.
Spontaneous remission-some cases.
Meticulous oral hygiene.
Scaling, irrigation with chlorhexidine.
Recall after 2-3 weeks.
Persistent cases-treat for candida infection.
Management
Cleaning and debridement.
Oral hygiene instructions.
Systemic antibiotics-metronidazole and
amoxycillin.
Re-evaluation after 1 month.
Osseous necrosis - remove the affected bone to
promote wound healing.